Clinical data on Covid bivalent booster jabs is MISSING
Clinical data on Covid bivalent booster jabs is MISSINGDescription
Clinical data on Covid bivalent booster jabs is MISSING_ collusion between FDA, CDC and Moderna to blame
Summary
What is already known about this topic?
Bivalent COVID-19 booster vaccines increase protection against infection and severe disease. However, few eligible U.S. residents have received a bivalent booster dose, and factors underlying low coverage are unclear.
What is added by this report?
An online opt-in survey of 1,200 previously vaccinated U.S. residents found that the most common reasons for not getting a bivalent booster dose were lack of awareness about eligibility or availability and overconfidence in immunity; reasons varied by age group.
What are the implications for public health practice?
All eligible adults should receive a bivalent COVID-19 booster vaccine. To help increase bivalent booster dose coverage, health care and public health professionals should use evidence-based strategies to inform persons about booster vaccine recommendations and waning immunity.
United States
